- Home
- CMBM vs NTRB Comparison
CMBM vs NTRB Comparison
Compare CMBM & NTRB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CMBM
- NTRB
- Stock Information
- Founded
- CMBM 2011
- NTRB 2016
- Country
- CMBM United States
- NTRB United States
- Employees
- CMBM N/A
- NTRB N/A
- Industry
- CMBM Radio And Television Broadcasting And Communications Equipment
- NTRB Industrial Specialties
- Sector
- CMBM Technology
- NTRB Health Care
- Exchange
- CMBM Nasdaq
- NTRB Nasdaq
- Market Cap
- CMBM 26.5M
- NTRB 77.9M
- IPO Year
- CMBM 2019
- NTRB N/A
- Fundamental
- Price
- CMBM $0.72
- NTRB $4.08
- Analyst Decision
- CMBM Strong Buy
- NTRB
- Analyst Count
- CMBM 3
- NTRB 0
- Target Price
- CMBM $5.50
- NTRB N/A
- AVG Volume (30 Days)
- CMBM 176.8K
- NTRB 30.1K
- Earning Date
- CMBM 02-13-2025
- NTRB 12-04-2024
- Dividend Yield
- CMBM N/A
- NTRB N/A
- EPS Growth
- CMBM N/A
- NTRB N/A
- EPS
- CMBM N/A
- NTRB N/A
- Revenue
- CMBM $172,215,000.00
- NTRB $2,021,771.00
- Revenue This Year
- CMBM N/A
- NTRB N/A
- Revenue Next Year
- CMBM $16.49
- NTRB N/A
- P/E Ratio
- CMBM N/A
- NTRB N/A
- Revenue Growth
- CMBM N/A
- NTRB N/A
- 52 Week Low
- CMBM $0.66
- NTRB $2.22
- 52 Week High
- CMBM $6.50
- NTRB $9.60
- Technical
- Relative Strength Index (RSI)
- CMBM 29.36
- NTRB 40.82
- Support Level
- CMBM $0.68
- NTRB $3.87
- Resistance Level
- CMBM $0.81
- NTRB $4.80
- Average True Range (ATR)
- CMBM 0.11
- NTRB 0.51
- MACD
- CMBM -0.03
- NTRB 0.04
- Stochastic Oscillator
- CMBM 10.79
- NTRB 21.21
About CMBM Cambium Networks Corporation
Cambium Networks Corp provides wireless broadband networking infrastructure solutions for network operators, including medium-sized wireless Internet service providers, enterprises, and government agencies. The company geographically operates in North America; Europe, Middle East and Africa; Caribbean and Latin America; and Asia Pacific. It derives maximum revenue from North America.
About NTRB Nutriband Inc.
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's lead product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.